On July 5, 2026, leading oncologists in Dubai and Abu Dhabi highlighted the growing demand for advanced immunotherapy and targeted therapies in the Middle East, along with new cold-chain logistics guidelines. Ensuring reliable access to critical treatments like Keytruda (Pembrolizumab) and Herceptin (Trastuzumab) is vital for clinics managing complex cancer patients across the UAE.

At Onco Medicine, we operate a GDP-certified cold-chain distribution network to supply Emirati medical facilities and private patients. Our logistics systems ensure that temperature-sensitive biologics remain stable throughout their journey to the UAE.

Ensuring Safe Imports to the UAE

• MOHAP Regulations: Sourcing specialty medications requires compliance with the UAE Ministry of Health and Prevention guidelines. A valid prescription is essential for clearing imports.
• Active Temperature Monitoring: Biologics must be kept strictly between 2°C and 8°C. We pack our shipments in validated thermal containers with active data loggers to record temperature at every stage.
• Fast Transit to All Emirates: Priority air logistics routes allow direct delivery to clinics in Dubai, Abu Dhabi, Sharjah, and other Emirates within 5 to 9 business days.

Bridging access gaps for advanced cancer care is a logistics challenge we proudly meet. By combining pharmaceutical expertise with rigorous cold-chain protocols, Onco Medicine ensures that clinics across the UAE receive original, high-quality oncology products with full batch traceability. We remain a trusted logistics partner in the region.